McMurray, J. J., DeMets, D. L., Inzucchi, S. E., Køber, L., Kosiborod, M. N., Langkilde, A. M., . . . Solomon, S. D. (2019). A trial to evaluate the effect of the sodium–glucose co‐transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA‐HF). Eur J Heart Fail.
Chicago-стиль цитированияMcMurray, John J.V., et al. "A Trial to Evaluate the Effect of the Sodium–glucose Co‐transporter 2 Inhibitor Dapagliflozin On Morbidity and Mortality in Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction (DAPA‐HF)." Eur J Heart Fail 2019.
MLA-цитированиеMcMurray, John J.V., et al. "A Trial to Evaluate the Effect of the Sodium–glucose Co‐transporter 2 Inhibitor Dapagliflozin On Morbidity and Mortality in Patients With Heart Failure and Reduced Left Ventricular Ejection Fraction (DAPA‐HF)." Eur J Heart Fail 2019.